About the Journal
Advancing clinically relevant discovery, translation, and evidence-informed healthcare.
Avicenna Journal of Clinical and Translational Medicine (AJCTM) is a peer-reviewed, open-access scholarly journal published by Avicenna Medical Press (AMP). The journal provides an international forum for scientifically rigorous research that connects biomedical discovery, clinical investigation, therapeutic innovation, and patient-centred healthcare.
AJCTM welcomes original investigations and scholarly contributions that advance the understanding, prevention, diagnosis, treatment, and management of human disease. Particular emphasis is placed on research with clear clinical relevance, methodological integrity, and the potential to inform clinical practice or future translational investigation.
Aims and Scientific Scope
The journal welcomes research across clinical and translational medicine, including:
- Clinical and patient-oriented research
- Cardiovascular medicine and related disciplines
- Clinical pharmacology, therapeutics, and drug development
- Translational and experimental medicine
- Molecular and cellular mechanisms of human disease
- Biomarkers, diagnostics, and precision medicine
- Clinical trials and therapeutic interventions
- Medical technologies and evidence-based innovation
- Epidemiology and population research with direct clinical relevance
- Implementation and health-services research addressing clinical outcomes
Submissions from other medical specialties are considered where they make a substantive contribution to clinical understanding, therapeutic advancement, or the translation of research into healthcare.
Article Categories
AJCTM considers Original Research Articles, Review Articles, Case Reports, Short Communications, and Editorials. Publication of specific article categories may be subject to editorial invitation or prior assessment of suitability.
Peer Review and Editorial Independence
Research submissions undergo editorial screening followed, where appropriate, by independent external peer review. The journal follows a double-anonymized peer-review model. Editorial decisions are based on scientific merit, originality, methodological quality, ethical compliance, and relevance to the journal's scope.
Editorial decisions remain independent of commercial or financial considerations. Payment of publication charges, where applicable, does not guarantee acceptance.
Open Access and Copyright
AJCTM supports immediate open access to published scholarly content. Its intended standard publishing licence is the Creative Commons Attribution 4.0 International (CC BY 4.0), allowing sharing and adaptation with appropriate attribution. Authors should consult the journal's Copyright and Licensing Policy for full conditions.
Publication Ethics
The journal is committed to internationally recognized principles of responsible research and scholarly publication. Its editorial policies are informed by guidance from the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).
Authors are expected to disclose relevant conflicts of interest, obtain applicable research ethics approvals, provide informed consent where required, and ensure the integrity and transparency of their findings.
Publication Model
AJCTM follows a biannual issue structure, with continuous online publication of accepted articles as they become ready for publication. Publication fees, waivers, and author responsibilities are described separately in the journal's author information and policy pages.
Publisher and Correspondence
Publisher: Avicenna Medical Press (AMP)
Journal: Avicenna Journal of Clinical and Translational Medicine
Editorial correspondence: editor@ajctm.org
Website: www.ajctm.org
To support high-quality clinical and translational scholarship that advances scientific understanding and contributes to better healthcare decisions and patient outcomes.



